Karen M. West
President and Chief Executive Officer, Solesis
As CEO, Karen West applies her passion for the Solesis, LLC mission and vision to lead organic and acquisitive growth and market expansion into implantable medical device and drug delivery markets with innovative new products, including an IP-protected technology platform, for Solesis and its subsidiaries.
Karen played a key role in changing the business structure of Solesis and establishing it as an independent company . Working with Michelin, who owned Solesis at the time, Karen drove organic growth for the medical division and contributed to global leadership as a member of the strategic operating group executive committee.
Following Secant Medical’s acquisition by Fenner PLC, Karen expanded the portfolio into medical devices, doubling sales over three years and achieving record operating profits. She established and ran Solesis as a medical division inside Fenner, serving as the first woman on the executive committee in 160 years. Karen helped establish a foothold in the biopharmaceutical manufacturing and cell and gene therapy market and improved Solesis’ overall P&L performance and profitability.
In 2002, Karen co-founded and established Secant Medical, LLC, transforming industrial manufacturing facilities to facilities for designing and manufacturing implantable medical textiles, building a more robust quality-focused organization and launching an internal research organization.
With broad executive experience across diverse business functions and organizations, from a family-owned enterprise and startups to global public and private-equity-funded companies, Karen applies her energy and tenacity to transform companies and drive revenue and profit growth.
Karen holds a master’s in business administration and a certificate of corporate entrepreneurship from Lehigh University, and a bachelor’s degree from Jefferson University.
Christopher B. Edwards
Chief Financial Officer, Solesis
Chris Edwards joined the Solesis team in 2013. He is responsible for all finance activities across the Solesis operating companies: Secant Group, SanaVita Medical, and Charter Medical. As CFO, Chris works alongside the president of Solesis, Karen West, to oversee the development and expansion of the business.
Previously, Chris worked for Bristol-Myers Squibb, ConvaTec, and Syneos Health, in Europe, the Middle East, Africa, and the United States, which gave him a solid underpinning in global finance. Chris has spent time building finance teams, setting up shared services models, supporting senior leadership, and managing acquisitions and divestitures.
In his leadership role, Chris is instrumental in pursuing the division’s business development strategies and focuses on guiding and developing the financial leadership teams at Solesis’s operating companies.
Chris holds a master’s in business administration from the Manchester Business School, UK, and is a chartered global management accountant (CGMA) qualifying in Liverpool, UK.
Chief Operating Officer, Solesis
Jeff Robertson serves as Chief Operating Officer of Solesis and President of the Secant Group, SanaVita Medical, and Charter Medical. He joined Secant as a vice president in 2011, during which time he managed the strategic oversight of business development, marketing, client accounts, product development, and operations.
Previously, Jeff worked at ARmark Authentication Technologies, LLC, a wholly owned subsidiary of Adhesives Research, Inc. Robertson co-developed ARmark Authentication Technologies in 2005 and served as the director and general manager.
Previously, Jeff held various positions at Adhesives Research including general manager of a global business unit. He began his career in pharmaceutical sales at Bristol-Meyers Squibb and handled the opening of a new state organization for Bock Pharmaceuticals. Jeff earned a master’s in business administration from Kennedy-Western University and a bachelor’s degree in Bio-Behavioral Science (pre-med) from Colby College.
Get in Touch with Us
To learn more about what we do or how we can work together, send us an inquiry and we will respond as soon as possible.